Inventor · disambiguated record
Michael Kowarik
Also filed as: KOWARIK MICHAEL · KOWARIK MICHAEL T · KOWARIK MICHAEL THOMAS
35 granted patents·17 pending applications·145 citations·filing 2006–2025
96Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA30GLYCOVAXYN AG6JANSSEN PHARMACEUTICALS INC6ETH Zürich2ISIS INNOVATION2
Top patents by PatentIndex Score
52 records- 0196US10940192B2Polysaccharide and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Mar 9, 2021·11 cites·20 claims
- 0294US11015177B2Compositions and methods for protein glycosylationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted May 25, 2021·11 cites·20 claims
- 0394US10577592B2Compositions and methods for protein glycosylationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Mar 3, 2020·12 cites·19 claims
- 0494US9700612B2Polysaccharide and uses thereofGLYCOVAXYN AG·Filed 2015·Granted Jul 11, 2017·27 cites·20 claims
- 0593US11738076B2Polysaccharide and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Granted Aug 29, 2023·2 cites·22 claims
- 0693US10583185B2Methods and compositions for immune protection against extra-intestinal pathogenic E. coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Mar 10, 2020·12 cites·20 claims
- 0793US10441647B2Polysaccharide and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Oct 15, 2019·13 cites·20 claims
- 0893US10150952B2Compositions and methods for protein glycosylationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Granted Dec 11, 2018·12 cites·14 claims
- 0992US11446370B2Bioconjugates of E. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Sep 20, 2022·6 cites·42 claims
- 1092US8871491B2Capsular gram-positive bacteria bioconjugate vaccinesWACKER MICHAEL·Filed 2011·Granted Oct 28, 2014·12 cites·17 claims
- 1187US9585950B2Capsular gram-positive bacteria bioconjugate vaccinesGLYCOVAXYN AG·Filed 2014·Granted Mar 7, 2017·5 cites·25 claims
- 1285US12214029B2Polysaccharide and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2023·Granted Feb 4, 2025·0 cites·20 claims
- 1385US11931405B2Bioconjugates of E. coli O-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Mar 19, 2024·1 cites·22 claims
- 1484US8895014B2Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cellsFERNANDEZ FABIANA·Filed 2009·Granted Nov 25, 2014·11 cites·13 claims
- 1581US12442019B2Process for the manipulation of nucleic acidsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2024·Granted Oct 14, 2025·0 cites·13 claims
- 1681US2024277824A1Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cellsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2024·Application pending·0 cites
- 1778US11959092B2Process for the manipulation of nucleic acidsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Apr 16, 2024·1 cites·4 claims
- 1877US12076385B2Methods and compositions for immune protection against extra-intestinal pathogenic E. coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Sep 3, 2024·0 cites·22 claims
- 1977US10195262B2Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2014·Granted Feb 5, 2019·3 cites·8 claims
- 2077US8753864B2Recombinant N-glycosylated proteins from procaryotic cellsAEBI MARKUS·Filed 2006·Granted Jun 17, 2014·4 cites·7 claims
- 2176US12233121B2Methods of producing bioconjugates of E. coli O-antigen polysaccharides, compositions thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Feb 25, 2025·0 cites·8 claims
- 2272US12398380B2Methods of host cell modificationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Granted Aug 26, 2025·0 cites·5 claims
- 2372US2024316172A1Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2471US11944675B2Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cellsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Apr 2, 2024·0 cites·7 claims
- 2571US10835592B2Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cellsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2014·Granted Nov 17, 2020·0 cites·9 claims
- 2670US11236136B2Methods of producing glycosylated proteinsLIMMATECH BIOLOGICS AG·Filed 2016·Granted Feb 1, 2022·1 cites·13 claims
- 2767US2024100140A1Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2023·Application pending·0 cites
- 2866US12128096B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Oct 29, 2024·0 cites·13 claims
- 2966US2025222093A1Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3065US11484582B2Methods and compositions for immune protection against extra-intestinal pathogenic E. coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Nov 1, 2022·0 cites·20 claims
- 3165US10307473B2Capsular gram-positive bacteria bioconjugate vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Jun 4, 2019·0 cites·8 claims
- 3264US11491220B2Methods of producing bioconjugates of E. coli o-antigen polysaccharides, compositions thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 8, 2022·0 cites·6 claims
- 3364US10287330B2Methods and compositions relating to CRM197GLAXOSMITHKLINE BIOLOGICAL S A·Filed 2013·Granted May 14, 2019·1 cites·27 claims
- 3461US2022025419A1N-glycosylation of peptides and proteinsISIS INNOVATION·Filed 2021·Application pending·0 cites
- 3560US11220676B2Methods of host cell modificationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2014·Granted Jan 11, 2022·0 cites·12 claims
- 3660US2025381257A1VaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 3760US2023293657A1VaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 3859US2019218561A1Methods of host cell modificationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Application pending·0 cites
- 3959US2022242919A1Methods of producing glycosylated proteinsLIMMATECH BIOLOGICS AG·Filed 2021·Application pending·0 cites
- 4057US11654190B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted May 23, 2023·0 cites·5 claims
- 4157US10973901B2Production of recombinant vaccine in E. coli by enzymatic conjugationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Apr 13, 2021·0 cites·16 claims
- 4257US9551019B2Recombinant N-glycosylated proteins from procaryotic cellsETH Zürich·Filed 2014·Granted Jan 24, 2017·0 cites·21 claims
- 4355US2024139304A1P aeruginosa pcrv-linked antigen vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 4453US11376314B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Jul 5, 2022·0 cites·16 claims
- 4553US2015267207A1Methods of host cell modificationGLYCOVAXYN AG·Filed 2013·Application pending·0 cites
- 4650US2016257983A1N-glycosylation of peptides and proteinsISIS INNOVATION·Filed 2014·Application pending·0 cites
- 4749US2015273043A1Production of recombinant vaccine in e.coli by enzymatic conjugationGLYCOVAXYN AG·Filed 2013·Application pending·0 cites
- 4847US2022054632A1Modified carrier proteins for o-linked glycosylationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Application pending·0 cites
- 4947US2016326563A1Recombinant n-glycosylated proteins from procaryotic cellsETH Zürich·Filed 2016·Application pending·0 cites
- 5042US2015238596A1Bioconjugates comprising modified antigens and uses thereofGLYCOVAXYN AG·Filed 2013·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →